Fluticasone propionate is a corticosteroid derived fromfluticasone used to treat asthma and allergic rhinitis. It is also used to treat eosinophilic esophagitis.GlaxoSmithKline currently markets fluticasone propionate asFlovent (USA and Canada) and Flixotide (EU) for asthma, and as Flonase (USA and Canada), Flixonase (Australia, Brazil, EU, India, Israel, South Africa, and South Korea) and Pirinase (UK) for allergic rhinitis (hay fever), as well as a combination of fluticasone and salmeterol asAdvair (USA and Canada) or Seretide[1] (EU). In India it is also marketed by Intas under the trade name 'Ezicas'.
EzicasTeva markets fluticasone propionate as Nasofan in Italy. It is available asFluticone in India. It is also available as a cream (marketed as Cutivate orFlutivate) for the treatment of eczema and psoriasis.
EzicasTeva markets fluticasone propionate as Nasofan in Italy. It is available asFluticone in India. It is also available as a cream (marketed as Cutivate orFlutivate) for the treatment of eczema and psoriasis.
Fluticasone propionate is a synthetic trifluorinated glucocorticoid.
No comments:
Post a Comment